Amélie Lothe, PhD, discusses findings showing early, sustained benefits of fenfluramine treatment for patients with Lennox-Gastaut syndrome.
Amelie Lothe, PhD
Advertisement
Amelie Lothe, PhD, is Global Medical Community Head for Rare Epilepsies at UCB.
Articles by Amelie Lothe, PhD
Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What's new in IDSA's histoplasmosis treatment guidance?
2
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
3
Predictability may be an overlooked factor in children's mental health
4
Dietary modulation of gut microbes extends survival in Hirschsprung disease mouse model
5